Language selection

Government of Canada / Gouvernement du Canada

Search

POL-0004 : drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement policy.: H139-40/2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.909298&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
TitlePOL-0004 : drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement policy.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: POL-0004 : Politique d'application de la loi pour les bonnes pratiques de fabrication (BPF) des médicaments et les licences d’établissement de produits pharmaceutiques (LEPP).
  • Issued also in HTML format.
  • Replaces: Good Manufacturing Practices (GMP) and Establishment Licensing Enforcement Directive, v3 (August 31, 2018).
  • "April 1, 2022."
Publishing information
  • [Ottawa] : Health Canada = Santé Canada, 2022.
  • ©2022
Description1 online resource (17 pages)
ISBN9780660426587
Catalogue number
  • H139-40/2022E-PDF
Departmental catalogue number210747
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: